Orexin-A potentiates glycine currents by activating OX1R and IP3/Ca2+/PKC signaling pathways in spinal cord ventral horn neurons

Brain Res Bull. 2021 Apr:169:196-204. doi: 10.1016/j.brainresbull.2021.01.017. Epub 2021 Jan 27.

Abstract

Orexin-A/B modulates multiple physical functions by activating their receptors (OX1R and OX2R), but its effects in the spinal cord motor control remain unknown. Using acute separation (by digestive enzyme) of cells and patch-clamp recordings, we aimed to investigate the effect and mechanisms of orexin-A on the glycine receptors in the spinal cord ventral horn neurons. Orexin-A potentiated the glycine currents by activating OX1R. In Ca2+-free extracellular solution, orexin-A still increased the glycine currents. While, the orexin-A-induced potentiation was blocked when Ca2+ was chelated by internal infusion of BAPTA, and the orexin-A effect was abolished by the IP3 receptor antagonists heparin and Xe-C. The PKC inhibitor Bis-IV nullified the orexin-A effect. In addition, orexin-A did not cause a further enhancement of the glycine currents after bath application of the PKC activator PMA. In conclusion, after OX1R is activated, a distinct IP3/Ca2+-dependent PKC signaling pathway, is likely responsible for the orexin-A potentiation on glycine currents in the spinal cord ventral horn neurons.

Keywords: Glycine receptors (GlyRs); Orexin receptors (OXRs); Orexin-A; Patch-clamp recordings; Spinal cord ventral horn neurons.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anterior Horn Cells / drug effects*
  • Anterior Horn Cells / metabolism
  • Calcium / metabolism
  • Glycine / metabolism*
  • Orexin Receptors / metabolism*
  • Orexins / pharmacology*
  • Protein Kinase C / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / drug effects*
  • Spinal Cord Ventral Horn / drug effects*
  • Spinal Cord Ventral Horn / metabolism

Substances

  • Orexin Receptors
  • Orexins
  • Protein Kinase C
  • Calcium
  • Glycine